Based on our advanced algorithm, we predict that GANX stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $3.5, while the 1-week outlook suggests a value of $3.6. For the 1-month forecast, we project a price of $3.8. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GANX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
GANX stock price ended at $3.5 on Thursday, after rising5.42%
The Gain Therapeutics Inc stock price increased by 5.42% on the last trading day (04 Dec 2025), rising from 3.31 to 3.5. Throughout the last trading session, the stock experienced a fluctuation of 10.33% , ranging from a day low of $3.1724 to a day high of 3.5. The price has declined in 3 of the last 10 days, resulting in a total change of 27.27% during this period. On the last day, trading volume decrease by -102.10K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 879.33K shares were traded, amounting to approximately 2.97M.
GANX Technical Signals
GANX(Gain Therapeutics Inc Corp) has 3 buy signals and 2 sell signals now. The current trend is a downtrend starting from 2025-11-28. The total price change during this trend is +0.00%. Recently, the price has increased significantly while volume increased, indicating a strong bullish signal. The average turnover of GANX over the last 5 trading days is 3.41M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
GANX Moving Average Analysis
Gain Therapeutics Inc's overall moving average trend leans more bullish as of Friday, December 5, 2025, with 0 negative signals and 4 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $3.76, and $4.17. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.47, and $2.07. A break-down below any of these levels will issue sell signals.
GANX Short Selling Analysis
The short sale ratio of Gain Therapeutics Inc(GANX) as of 03 Dec 2025 is 31.85%, rising from last trading day. With increasing price from 3.06 to 3.32. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
2
Buy
3
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.842
Bullish
Momentum (10 days)
MOM_10 > 0
0.75
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.323
Bullish
2 Bearish Signals
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Gain Therapeutics Inc (GANX) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Gain Therapeutics Inc Stock Forecast 2026
GANX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Gain Therapeutics Inc(GANX), our algorithm predicts GANX's 1-month price at $3.29, with an -5.91%downwardshift. Using a similarity score up to 98.43%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Gain Therapeutics Inc (GANX.O) stock, as of Monday, December 1, 2025 , forecasts a -5.91% change over the next month, based on its high correlation with BBY.N stock patterns. The similarity between their price movements over the analyzed periods is 98.43%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
GANX
No Data
BBY
Down: -5.91%Similarity: 98.43%
Name
Similarity
Up/Down
BBY.N
98.43%
-5.91%
BXP.N
98.35%
+2.44%
XHG.O
98.18%
-38.49%
AON.N
98.16%
+6.29%
WK.N
98.16%
+15.06%
VIOT.O
98.15%
+9.88%
RAIL.O
98.14%
+16.59%
SMC.N
98.14%
+12.64%
OKLO.N
98.02%
+1.93%
ACRE.N
97.96%
+0.36%
GANX Seasonality Analysis
Based on GANX's historical stock price data across all years, the probability of a positive return in December is60.00%, suggesting it maybe an ideal month to invest in GANX. In contrast,Octoberoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Gain Therapeutics Inc (GANX.O) stock in October has the highest probability of a positive return (60.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows Gain Therapeutics Inc. (GANX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Gain Therapeutics Inc (GANX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GANX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Gain Therapeutics Inc (GANX.O) stock in a year?
The radar chart shows that buying Gain Therapeutics Inc (GANX.O) stock in October has the highest probability of a positive return (60.00%), while May has the lowest probability (0.00%).
How has Gain Therapeutics Inc. (GANX)'s stock price performed over the past three years?
GANX's stock price rose by 0.77% in 2023,decreased by -40.41% in 2024, and went up by 50.86%in 2025.
Is GANX a buy based on overall technical signals summary?
GANX has 3 buy signals and 2 sell signals now. Overall the technical rating for GANX is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of GANX.
What is the trend of Gain Therapeutics Inc (GANX)'s moving average?
Gain Therapeutics Inc's overall moving average trend leans more bullish as of December 05 2025, with 0 negative signals and 4 positive signal.
What is price prediction for GANX stock next month?
The price prediction chart for Gain Therapeutics Inc (GANX.O) stock, as of December 01 2025, forecasts a -5.91% change over the next month, based on its high correlation with BBY stock patterns. The similarity between their price movements over the analyzed periods is 98.43%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Gain Therapeutics Inc (GANX) Stock?
In , Gain Therapeutics Inc's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.
What is price prediction 2030 for Gain Therapeutics Inc (GANX) Stock?
In , Gain Therapeutics Inc's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.